Exchange: NYSE·Updated 07:30 PM EDT
News
all
press releases
Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced findings from a new survey highlighting a significant awareness gap around dry eye and its association with perimenopause and menopause. The survey...
Business Wire
More News
Bausch + Lomb Advances Two First-in-Class Eye Health Therapies
BLCO advances two eye-health candidates after positive trial results, with combined estimated peak sales exceeding $2 billion.
Zacks
Bausch + Lomb Advances Two Eye Therapies With Blockbuster Sales Potential
Bausch + Lomb (NYSE: BLCO) advances two first-in-class eye drugs to advanced clinical testing, eyeing $2B+ in peak sales.read more...
Benzinga
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that two of its pharmaceutical pipeline assets both first-in-class treatments will advance to new trials based on recent clinical results. Helping...
Business Wire
COO Stock Surges 22% in Past Three Months: What's Driving the Uptrend?
Cooper Companies' 22% three-month surge reflects contact lens share gains, MiSight growth and a recovering fertility business.
Zacks
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board PR Newswire LAVAL, QC, Aug. 6, 2026 LAVAL, QC, Aug. 6, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) ("Bausch Health" or the "Company"),today announced...
PR Newswire
Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced changes to its Board of Directors. At the request of Bausch Health Companies Inc. (Bausch Health), which has held a majority ownership position in...
Business Wire
Bausch + Lomb (BLCO) Q2 Earnings Meet Estimates
Bausch + Lomb (BLCO) delivered earnings and revenue surprises of 0.00% and +1.92%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Bausch + Lomb Delivers Broad-Based Second-Quarter Growth, Raises Full-Year 2026 Guidance
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its second-quarter 2026 financial results. Broad-based revenue growth, leverage in the P&L, margin expansion and conversion to cash flow. These have...
Business Wire
Bausch + Lomb Launches EyeGility Inserter for enVista IOLs in the U.S.
BLCO launches EyeGility in the United States, pairing preloaded enVista Aspire lenses with smoother handling, one-handed use and surgical flexibility.
Zacks

Advertisement|Remove ads.